AbbVie Inc. Capital Expenditures
AbbVie Inc. (ABBV) reported Capital Expenditures of $587.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- AbbVie Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $322.00M, a 19.70% increase year-over-year.
- AbbVie Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $265.00M, a 12.77% increase year-over-year.
- AbbVie Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $329.00M, a 13.06% increase year-over-year.
- AbbVie Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $381.00M, a 53.01% increase year-over-year.
- AbbVie Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.21B, a 24.64% increase from fiscal 2024.
- AbbVie Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $974.00M, a 25.35% increase from fiscal 2023.
- AbbVie Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $777.00M, a 11.80% increase from fiscal 2022.
- AbbVie Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $695.00M, a 11.69% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $322.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $587.00M 10-Q · filed 2026-08-03 | $916.00M derived: sum of 3 quarters · filed 2026-08-03 | $1.30B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $265.00M 10-Q · filed 2026-05-08 | $594.00M derived: sum of 2 quarters · filed 2026-05-08 | $975.00M derived: sum of 3 quarters · filed 2026-05-08 | $1.24B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $710.00M derived: sum of 2 quarters · filed 2026-02-20 | $979.00M derived: sum of 3 quarters · filed 2026-08-03 | $1.21B 10-K · filed 2026-02-20 |
| 2025-09-30 | $381.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $650.00M derived: sum of 2 quarters · filed 2026-08-03 | $885.00M 10-Q · filed 2025-11-04 | $1.18B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $269.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $504.00M 10-Q · filed 2026-08-03 | $795.00M derived: sum of 3 quarters · filed 2026-08-03 | $1.04B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $235.00M 10-Q · filed 2026-05-08 | $526.00M derived: sum of 2 quarters · filed 2026-05-08 | $775.00M derived: sum of 3 quarters · filed 2026-05-08 | $1.02B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $291.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $540.00M derived: sum of 2 quarters · filed 2026-02-20 | $781.00M derived: sum of 3 quarters · filed 2026-02-20 | $974.00M 10-K · filed 2026-02-20 |
| 2024-09-30 | $249.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $490.00M derived: sum of 2 quarters · filed 2025-11-04 | $683.00M 10-Q · filed 2025-11-04 | $888.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $241.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $434.00M 10-Q · filed 2025-08-04 | $639.00M derived: sum of 3 quarters · filed 2026-02-20 | $858.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $193.00M 10-Q · filed 2025-05-09 | $398.00M derived: sum of 2 quarters · filed 2026-02-20 | $617.00M derived: sum of 3 quarters · filed 2026-02-20 | $795.00M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $205.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $424.00M derived: sum of 2 quarters · filed 2026-02-20 | $602.00M derived: sum of 3 quarters · filed 2026-02-20 | $777.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $219.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $397.00M derived: sum of 2 quarters · filed 2024-11-04 | $572.00M 10-Q · filed 2024-11-04 | $785.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $178.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $353.00M 10-Q · filed 2024-08-07 | $566.00M derived: sum of 3 quarters · filed 2025-02-14 | $743.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $175.00M 10-Q · filed 2024-05-03 | $388.00M derived: sum of 2 quarters · filed 2025-02-14 | $565.00M derived: sum of 3 quarters · filed 2025-02-14 | $708.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $213.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $390.00M derived: sum of 2 quarters · filed 2025-02-14 | $533.00M derived: sum of 3 quarters · filed 2025-02-14 | $695.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $177.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $320.00M derived: sum of 2 quarters · filed 2023-11-06 | $482.00M 10-Q · filed 2023-11-06 | $669.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $143.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $305.00M 10-Q · filed 2023-08-07 | $492.00M derived: sum of 3 quarters · filed 2024-02-20 | $709.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $162.00M 10-Q · filed 2023-05-05 | $349.00M derived: sum of 2 quarters · filed 2024-02-20 | $566.00M derived: sum of 3 quarters · filed 2024-02-20 | $761.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $187.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $404.00M derived: sum of 2 quarters · filed 2024-02-20 | $599.00M derived: sum of 3 quarters · filed 2024-02-20 | $787.00M 10-K · filed 2024-02-20 |
| 2021-09-30 | $217.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $412.00M derived: sum of 2 quarters · filed 2022-11-04 | $600.00M 10-Q · filed 2022-11-04 | $879.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $195.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $383.00M 10-Q · filed 2022-08-04 | $662.00M derived: sum of 3 quarters · filed 2023-02-17 | $879.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $188.00M 10-Q · filed 2022-05-06 | $467.00M derived: sum of 2 quarters · filed 2023-02-17 | $684.00M derived: sum of 3 quarters · filed 2023-02-17 | $861.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $279.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $496.00M derived: sum of 2 quarters · filed 2023-02-17 | $673.00M derived: sum of 3 quarters · filed 2023-02-17 | $798.00M 10-K · filed 2023-02-17 |
| 2020-09-30 | $217.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $394.00M derived: sum of 2 quarters · filed 2021-11-02 | $519.00M 10-Q · filed 2021-11-02 | $682.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $177.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $302.00M 10-Q · filed 2021-08-02 | $465.00M derived: sum of 3 quarters · filed 2022-02-18 | $619.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $125.00M 10-Q · filed 2021-05-07 | $288.00M derived: sum of 2 quarters · filed 2022-02-18 | $442.00M derived: sum of 3 quarters · filed 2022-02-18 | $570.00M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $163.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $317.00M derived: sum of 2 quarters · filed 2022-02-18 | $445.00M derived: sum of 3 quarters · filed 2022-02-18 | $552.00M 10-K · filed 2022-02-18 |
| 2019-09-30 | $154.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $282.00M derived: sum of 2 quarters · filed 2020-11-04 | $389.00M 10-Q · filed 2020-11-04 | $512.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $128.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $235.00M 10-Q · filed 2020-08-04 | $358.00M derived: sum of 3 quarters · filed 2021-02-19 | $640.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $107.00M 10-Q · filed 2020-05-08 | $230.00M derived: sum of 2 quarters · filed 2021-02-19 | $512.00M derived: sum of 3 quarters · filed 2021-02-19 | $626.00M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $405.00M derived: sum of 2 quarters · filed 2021-02-19 | $519.00M derived: sum of 3 quarters · filed 2021-02-19 | $638.00M 10-K · filed 2021-02-19 |
| 2018-09-30 | $282.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $396.00M derived: sum of 2 quarters · filed 2019-11-06 | $515.00M 10-Q · filed 2019-11-06 | $697.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $114.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $233.00M 10-Q · filed 2019-08-05 | $415.00M derived: sum of 3 quarters · filed 2020-02-21 | $541.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $119.00M 10-Q · filed 2019-05-03 | $301.00M derived: sum of 2 quarters · filed 2020-02-21 | $427.00M derived: sum of 3 quarters · filed 2020-02-21 | $553.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $308.00M derived: sum of 2 quarters · filed 2020-02-21 | $434.00M derived: sum of 3 quarters · filed 2020-02-21 | $529.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | $126.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $252.00M derived: sum of 2 quarters · filed 2018-11-07 | $347.00M 10-Q · filed 2018-11-07 | $461.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $126.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $221.00M 10-Q · filed 2018-08-07 | $335.00M derived: sum of 3 quarters · filed 2019-02-27 | $448.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $95.00M 10-Q · filed 2018-05-04 | $209.00M derived: sum of 2 quarters · filed 2019-02-27 | $322.00M derived: sum of 3 quarters · filed 2019-02-27 | $453.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $227.00M derived: sum of 2 quarters · filed 2019-02-27 | $358.00M derived: sum of 3 quarters · filed 2019-02-27 | $479.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $113.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $244.00M derived: sum of 2 quarters · filed 2017-11-07 | $365.00M 10-Q · filed 2017-11-07 | $510.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $131.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $252.00M 10-Q · filed 2017-08-07 | $397.00M derived: sum of 3 quarters · filed 2018-02-16 | $524.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $121.00M 10-Q · filed 2017-05-05 | $266.00M derived: sum of 2 quarters · filed 2018-02-16 | $393.00M derived: sum of 3 quarters · filed 2018-02-16 | $508.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $145.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $272.00M derived: sum of 2 quarters · filed 2018-02-16 | $387.00M derived: sum of 3 quarters · filed 2018-02-16 | $532.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $242.00M derived: sum of 2 quarters · filed 2016-11-07 | $387.00M 10-Q · filed 2016-11-07 | $540.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $115.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $260.00M 10-Q · filed 2016-08-05 | $413.00M derived: sum of 3 quarters · filed 2017-02-17 | $593.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $145.00M 10-Q · filed 2016-05-06 | $298.00M derived: sum of 2 quarters · filed 2017-02-17 | $478.00M derived: sum of 3 quarters · filed 2017-02-17 | $620.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $153.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $333.00M derived: sum of 2 quarters · filed 2017-02-17 | $475.00M derived: sum of 3 quarters · filed 2017-02-17 | $612.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | $180.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $322.00M derived: sum of 2 quarters · filed 2015-11-06 | $459.00M 10-Q · filed 2015-11-06 | $610.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $142.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $279.00M 10-Q · filed 2015-08-07 | $430.00M derived: sum of 3 quarters · filed 2016-02-19 | $563.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $137.00M 10-Q · filed 2015-05-08 | $288.00M derived: sum of 2 quarters · filed 2016-02-19 | $421.00M derived: sum of 3 quarters · filed 2016-02-19 | $540.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $151.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $284.00M derived: sum of 2 quarters · filed 2016-02-19 | $403.00M derived: sum of 3 quarters · filed 2016-02-19 | $491.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | $133.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $252.00M derived: sum of 2 quarters · filed 2014-11-07 | $340.00M 10-Q · filed 2014-11-07 | $435.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $119.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $207.00M 10-Q · filed 2014-08-07 | $302.00M derived: sum of 3 quarters · filed 2015-02-20 | $284.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $88.00M 10-Q · filed 2014-05-09 | $183.00M derived: sum of 2 quarters · filed 2015-02-20 | $165.00M derived: sum of 3 quarters · filed 2015-02-20 | $259.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | $95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $77.00M derived: sum of 2 quarters · filed 2015-02-20 | $171.00M derived: sum of 3 quarters · filed 2015-02-20 | $333.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | -$18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $76.00M derived: sum of 2 quarters · filed 2013-11-12 | $238.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $94.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $256.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $162.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $356.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |